newsfilter.io
Podcast, Other

E71: Russia/Ukraine deep dive: escalation, risk factors, financial fallout, exit ramps and more

  • The conflict is characterized by high variance, with outcomes ranging from the rapid destruction of Kyiv to a long-term insurgency or potential regime change in Moscow.
  • Military escalation risks include a no-fly zone constituting direct shooting war with Russia, a rogue NATO action triggering Article 5, or a nuclear facility explosion causing an extinction-level event.
  • Economic warfare is viewed as a primary future mechanism involving asset seizures and supply route cut-offs, potentially saving lives compared to traditional combat but risking a lack of a calculated exit strategy similar to Iraq or Afghanistan.
  • Market volatility is expected if energy prices spike by 50%, likely triggering a global recession, while central banks may coordinate to provide liquidity and governments might subsidize commodities, driving massive deficits.
  • Russian economic contraction is projected to continue, with GDP having already decayed 35% over the last decade to $1.483 trillion after peaking at $2.292 trillion in 2013.
  • Financial system instability is predicted by month-end defaults or payment failures among counterparties due to the freezing of assets, though disinformation regarding nuclear attacks may be used to escalate tensions.
  • Geopolitical shifts are anticipated from a unipolar to a multipolar world order driven by China, with Ukrainian resilience serving as a deterrent against potential Chinese invasions of Taiwan.
  • US foreign policy objectives regarding regime change are viewed as a recipe for perpetual war and blocked ceasefires, whereas diplomatic de-escalation through removing NATO expansion from the table is considered a missed opportunity.
  • Long-term US financial obligations are expected to include several trillion dollars for humanitarian problems in emerging markets caused by sanctions.
  • In the biotechnology sector, CAR T therapies are predicted to become a multi-decade therapeutic modality, with costs potentially falling below $5,000 per treatment through engineering and scaling.
  • The All In Summit is scheduled to occur from May 15th to May 17th.